Cognition Therapeutics, Inc. (CGTX)

NasdaqGM - NasdaqGM Precio retrasado. Divisa en USD.

Añadir a la lista de seguimiento

1.8300

-0.0700

(-3.68%)

Al cierre: 04:00PM EDT

1.9200

+0.09

(+4.92%)

Fuera de horario:

05:56PM EDT

Accionistas principales

Nómina de miembros de la gerencia

Transacciones de miembros de la gerencia

Divisa en USD

Compras de miembros de la gerencia en los últimos 6 meses	Acciones	Trans
Compras	0	0
Ventas	N/D	0
Acciones netas compradas (vendidas)	0	0
Acciones totales pertenecientes a miembros de la gerencia	189.08k	N/D
Acciones netas compradas (vendidas) en %	N/D	N/D

Compras institucionales netas del trimestre anterior al último	Acciones
Acciones netas compradas (vendidas)	N/D
Cambio en acciones institucionales propias en %	N/D

Información confidencial de transacciones reportada (últimos dos años)

Miembro de la gerencia	Transacción	Tipo	Valor	Fecha	Acciones
RICCIARDI LISA Chief Executive Officer	Purchase at price 1.75 per share.	Directo	9,975	14 mar 2024	5,700
RICCIARDI LISA Chief Executive Officer	Stock Award(Grant) at price 0.00 per share.	Directo	0	15 feb 2024	75,000
DOYLE JOHN BRENDAN Chief Financial Officer	Stock Award(Grant) at price 0.00 per share.	Directo	0	15 feb 2024	20,000
CAGGIANO ANTHONY Officer	Stock Award(Grant) at price 0.00 per share.	Directo	0	15 feb 2024	60,000
FLETCHER AARON G.L. Director and Beneficial Owner of more than 10% of a Class of Security	Stock Award(Grant) at price 1.05 per share.	Indirecto	525,100	08 nov 2023	500,095
KREIS LESLIE W JR Director and Beneficial Owner of more than 10% of a Class of Security	Stock Award(Grant) at price 1.05 per share.	Indirecto	525,100	08 nov 2023	500,095
RICHSTONE ELLEN B Director	Stock Award(Grant) at price 0.00 per share.	Directo	0	09 jun 2023	6,000
KHATTAR JACK A Director	Stock Award(Grant) at price 0.00 per share.	Directo	0	09 jun 2023	6,000
MONIA BRETT P Director	Stock Award(Grant) at price 0.00 per share.	Directo	0	09 jun 2023	6,000
FLETCHER AARON G.L. Director and Beneficial Owner of more than 10% of a Class of Security	Stock Award(Grant) at price 0.00 per share.	Indirecto	0	09 jun 2023	6,000
WALLACE PEGGY Director	Stock Award(Grant) at price 0.00 per share.	Directo	0	09 jun 2023	6,000
DOYLE JOHN BRENDAN Chief Financial Officer	Stock Award(Grant) at price 0.00 per share.	Directo	0	01 may 2023	109,824
RICCIARDI LISA Chief Executive Officer	Stock Award(Grant) at price 0.00 per share.	Directo	0	03 feb 2023	213,973
CAGGIANO ANTHONY Officer	Stock Award(Grant) at price 0.00 per share.	Directo	0	03 feb 2023	94,406
RICHSTONE ELLEN B Director	Purchase at price 2.66 per share.	Directo	26,550	29 nov 2022	10,000
FLETCHER AARON G.L. Director and Beneficial Owner of more than 10% of a Class of Security	Purchase at price 2.65 per share.	Indirecto	42,565	28 nov 2022	16,064
KREIS LESLIE W JR Director and Beneficial Owner of more than 10% of a Class of Security	Purchase at price 2.65 per share.	Indirecto	42,565	28 nov 2022	16,064
FLETCHER AARON G.L. Director	Purchase at price 1.40 per share.	Indirecto	99,400	16 nov 2022	71,000
KREIS LESLIE W JR Director	Purchase at price 1.40 per share.	Indirecto	99,400	16 nov 2022	71,000
RICCIARDI LISA Chief Executive Officer	Purchase at price 1.30 per share.	Directo	15,600	15 nov 2022	12,000
FLETCHER AARON G.L. Director	Purchase at price 1.20 per share.	Indirecto	1,800,000	15 nov 2022	1,500,000
KREIS LESLIE W JR Director	Purchase at price 1.20 per share.	Indirecto	1,800,000	15 nov 2022	1,500,000
WALLACE PEGGY Director	Purchase at price 1.20 per share.	Directo	15,000	15 nov 2022	12,500
RICCIARDI LISA Chief Executive Officer	Purchase at price 12.00 per share.	Directo	150,000	13 oct 2021	12,500
O BRIEN JAMES MICHAEL Chief Financial Officer	Purchase at price 12.00 per share.	Directo	60,000	13 oct 2021	5,000
FLETCHER AARON G.L. Director	Purchase at price 12.00 per share.	Indirecto	2,280,000	13 oct 2021	190,000
FLETCHER AARON G.L. Director	Sale at price 12.00 per share.	Indirecto	1,083	13 oct 2021	90
FLETCHER AARON G.L. Director	Conversion of Exercise of derivative security at price 0.03 per share.	Indirecto	1,072	13 oct 2021	3,722,932
BIOS EQUITY PARTNERS, LP. Beneficial Owner of more than 10% of a Class of Security	Purchase at price 12.00 per share.	Indirecto	2,280,000	13 oct 2021	190,000
BIOS EQUITY PARTNERS, LP. Beneficial Owner of more than 10% of a Class of Security	Sale at price 12.00 per share.	Indirecto	1,083	13 oct 2021	90
BIOS EQUITY PARTNERS, LP. Beneficial Owner of more than 10% of a Class of Security	Conversion of Exercise of derivative security at price 0.03 per share.	Indirecto	1,072	13 oct 2021	2,298,918
BIOS EQUITY PARTNERS, LP. Beneficial Owner of more than 10% of a Class of Security		Indirecto		13 oct 2021	1,424,014
WALLACE PEGGY Director	Purchase at price 12.00 per share.	Directo	36,000	13 oct 2021	3,000
BIOS MEMORY SPV I, L.P. Beneficial Owner of more than 10% of a Class of Security	Purchase at price 12.00 per share.	Indirecto	2,280,000	13 oct 2021	190,000
BIOS MEMORY SPV I, L.P. Beneficial Owner of more than 10% of a Class of Security	Sale at price 12.00 per share.	Indirecto	1,083	13 oct 2021	90
BIOS MEMORY SPV I, L.P. Beneficial Owner of more than 10% of a Class of Security	Conversion of Exercise of derivative security at price 0.03 per share.	Indirecto	1,072	13 oct 2021	3,722,932
BIOS MEMORY SPV I, L.P. Beneficial Owner of more than 10% of a Class of Security		Indirecto		13 oct 2021	1,424,014
OGDEN CAP ASSOCIATES LLC Beneficial Owner of more than 10% of a Class of Security	Sale at price 12.00 per share.	Directo	889	13 oct 2021	74
OGDEN CAP ASSOCIATES LLC Beneficial Owner of more than 10% of a Class of Security	Conversion of Exercise of derivative security at price 0.03 per share.	Directo	879	13 oct 2021	2,210,452
GOLDEN SEEDS COGNITION THERAPEUTICS LLC Beneficial Owner of more than 10% of a Class of Security	Sale at price 12.00 per share.	Directo	397	13 oct 2021	33
GOLDEN SEEDS COGNITION THERAPEUTICS LLC Beneficial Owner of more than 10% of a Class of Security	Conversion of Exercise of derivative security at price 0.03 per share.	Directo	393	13 oct 2021	2,489,725
BREEDLOVE MARK H. Director	Sale at price 12.00 per share.	Indirecto	141	13 oct 2021	12
BREEDLOVE MARK H. Director	Conversion of Exercise of derivative security at price 0.03 per share.	Indirecto	139	13 oct 2021	404,451

S&P 5005,352.96-1.07(-0.02%)

Dow Jones38,886.17+78.84(+0.20%)

Nasdaq17,173.12-14.78(-0.09%)

Russell 20002,049.44-14.43(-0.70%)

Petróleo75.62+0.07(+0.09%)

Oro2,394.40+3.50(+0.15%)

Cognition Therapeutics, Inc. (CGTX)

Transacciones de miembros de la gerencia

Información confidencial de transacciones reportada (últimos dos años)

S&P 500
5,352.96
-1.07(-0.02%)

Dow Jones
38,886.17
+78.84(+0.20%)

Nasdaq
17,173.12
-14.78(-0.09%)

Russell 2000
2,049.44
-14.43(-0.70%)

Petróleo
75.62
+0.07(+0.09%)

Oro
2,394.40
+3.50(+0.15%)